Published in Gut on July 01, 1998
Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut (2001) 1.16
Commonly used bowel preparations have significant and different effects upon cell proliferation in the colon: a pilot study. BMC Gastroenterol (2008) 0.80
Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer. Cancers (Basel) (2010) 0.76
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (1992) 6.13
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology (1987) 2.39
Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet (1993) 2.37
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest (1993) 2.10
Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer (1974) 1.95
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93
Evolution of hereditary non-polyposis colorectal cancer. Gut (1992) 1.70
Diurnal fluctuations in the number of cells in mitosis and DNA synthesis in the jejunum of the mouse. Exp Cell Res (1969) 1.68
Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics (1994) 1.63
Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res (1988) 1.62
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst (1991) 1.57
Tritiated thymidine (phi p, phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res (1983) 1.42
Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II. Gastroenterol Clin North Am (1988) 1.37
Significance of the labeling index and labeling distribution as kinetic parameters in colorectal mucosa of cancer patients and DMH treated animals. Cancer (1982) 1.29
Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res (1991) 1.25
Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology (1991) 1.22
Potential pitfalls of [3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet (1981) 1.21
Cell kinetic indicators of premalignant stages of colorectal cancer. Cancer (1985) 1.07
Solitary myofibroma in adults: clinicopathological analysis of a series. Histopathology (1993) 1.04
Cell kinetics analysis of background colonic mucosa of patients with intestinal neoplasms by ex vivo autoradiography. Gut (1988) 1.02
Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut (1995) 1.01
Tritiated thymidine incorporation into epithelial cells of normal-appearing colorectal mucosa of cancer patients. J Natl Cancer Inst (1977) 1.00
Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet (1994) 0.97
Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer (1991) 0.97
Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle. Biochem Pharmacol (1979) 0.91
Precursors of colorectal carcinoma. Biopsy and biologic markers. Cancer (1992) 0.91
Rectal epithelial cell proliferation in a group of young adults. Influence of age and genetic risk for colon cancer. Cancer (1988) 0.90
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer (1991) 0.89
Crypt cell production rates at various sites around the colon in Wistar rats and humans. Gut (1992) 0.87
Reproducibility studies and effects of bowel preparations on measurements of rectal epithelial proliferation. Cancer Lett (1989) 0.85
Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis colorectal cancer. Histopathology (1997) 0.84
[Influence of rectal preparation by enema on cell proliferation in the normal rectal mucosa in man]. Gastroenterol Clin Biol (1984) 0.84
Early detection of colonic neoplasia in patients at high risk. Cancer (1977) 0.84
Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence. Cancer Epidemiol Biomarkers Prev (1993) 0.84
Colonic fermentation and markers of colorectal-cancer risk. Am J Clin Nutr (1992) 0.83
Cancer family syndrome: marker studies. Gastroenterology (1986) 0.81
Proliferation rate in hereditary nonpolyposis colon cancer. J Natl Cancer Inst (1991) 0.81
Influence of demographic parameters on rectal epithelial proliferation. Cancer Lett (1989) 0.80
Validation of a simple technique for the detection of abnormal mucosal cell replication in humans. Eur J Cancer Prev (1994) 0.80
Colorectal adenoma progression and genetic change: is there a link? Ann Med (1995) 0.80
The effect of colonic site of biopsy on cell proliferation profiles using BRDU incorporation as a measure of cell proliferation. Eur J Cancer Prev (1992) 0.79
Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation. Br J Cancer (1995) 0.78
Unicryptal loss of heterozygosity in hereditary non-polyposis colorectal cancer. Pathology (1994) 0.77
Comparison of the circadian variation in cell proliferation in normal and neoplastic colonic epithelial cells. Cancer Lett (1985) 0.77
Tissue hypertrophy and epithelial proliferation rate in the gut of rats fed on bread and haricot beans (Phaseolus vulgaris). Br J Nutr (1996) 0.76
Validation of proliferation indices as surrogate endpoint biomarkers. J Cell Biochem Suppl (1994) 0.76
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Molecular analysis of cellulose biosynthesis in Arabidopsis. Science (1998) 7.51
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med (1998) 6.86
AtPIN2 defines a locus of Arabidopsis for root gravitropism control. EMBO J (1998) 5.91
Auxin transport promotes Arabidopsis lateral root initiation. Plant Cell (2001) 5.82
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet (2007) 4.62
DiGeorge syndrome: part of CATCH 22. J Med Genet (1993) 4.30
Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia (2011) 3.97
Localization of the auxin permease AUX1 suggests two functionally distinct hormone transport pathways operate in the Arabidopsis root apex. Genes Dev (2001) 3.89
Transport of live animals for slaughter. Vet Rec (1991) 3.83
The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology (1995) 3.73
Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med (2001) 3.55
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Antibiotic resistance found in wild rodents. Nature (1999) 3.20
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med (1971) 3.10
Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex. J Natl Cancer Inst (1971) 2.94
Cowpox: reservoir hosts and geographic range. Epidemiol Infect (1999) 2.93
The SUR2 gene of Arabidopsis thaliana encodes the cytochrome P450 CYP83B1, a modulator of auxin homeostasis. Proc Natl Acad Sci U S A (2000) 2.71
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70
A clarification of transmission terms in host-microparasite models: numbers, densities and areas. Epidemiol Infect (2002) 2.69
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet (1995) 2.64
X-linked situs abnormalities result from mutations in ZIC3. Nat Genet (1997) 2.62
Hyponatraemia: mechanisms and management. Lancet (1981) 2.55
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet (1998) 2.48
Complete genome sequence of the genetically tractable hydrogenotrophic methanogen Methanococcus maripaludis. J Bacteriol (2004) 2.47
VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies? Am J Med Genet (1992) 2.47
Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med (1971) 2.46
Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med (1989) 2.45
Complex regulation of the TIR1/AFB family of auxin receptors. Proc Natl Acad Sci U S A (2009) 2.36
dishevelled is required during wingless signaling to establish both cell polarity and cell identity. Development (1994) 2.35
Perforin: more than just an effector molecule. Immunol Today (2000) 2.30
Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly. Mol Cell Biol (1996) 2.29
Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29
Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev (2004) 2.23
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21
Characterization of the supernumerary chromosome in cat eye syndrome. Science (1986) 2.19
Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol (1994) 2.19
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol (2001) 2.15
Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J Med Genet (1995) 2.13
Transmission dynamics of a zoonotic pathogen within and between wildlife host species. Proc Biol Sci (1999) 2.11
Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet (1992) 2.05
Ambulatory blood pressure in pregnancy: comparison of the Spacelabs 90207 and Accutracker II monitors with intraarterial recordings. Am J Obstet Gynecol (1995) 2.03
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
Brachmann-de Lange syndrome. Delineation of the clinical phenotype. Am J Med Genet (1993) 2.00
Interpretation of test results for feline infectious peritonitis. Vet Rec (1997) 1.99
Recent changes among human influenza viruses. Virus Res (2004) 1.98
Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med (1987) 1.95
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest (1998) 1.87
Murine natural killer cells and marrow graft rejection. Annu Rev Immunol (1992) 1.87
Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol (1993) 1.87
Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study. Eur J Neurol (2014) 1.85
The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity (1996) 1.84
Bioavailability of fluoride in drinking water: a human experimental study. J Dent Res (2005) 1.84
Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology (1998) 1.84
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet (2000) 1.80
Isolation and characterization of mutants defective in seed coat mucilage secretory cell development in Arabidopsis. Plant Physiol (2001) 1.77
Polar auxin transport in the wood-forming tissues of hybrid aspen is under simultaneous control of developmental and environmental signals. Proc Natl Acad Sci U S A (2003) 1.77
Evaluation of social problem solving in schizophrenia. J Abnorm Psychol (1994) 1.74
Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro. J Cell Physiol (1968) 1.74
Laparoscopic cholecystectomy as a safe and effective treatment for severe acute cholecystitis. BMJ (1992) 1.74
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
Williams syndrome. J Med Genet (1986) 1.72
Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr (1998) 1.70
Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination. Dis Colon Rectum (2001) 1.67
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet (1998) 1.65
A terminal deletion of the long arm of chromosome 4 [46,XX,del(4)(q33)] in an infant with phenotypic features of Williams syndrome. J Med Genet (1986) 1.65
Serological evidence for the reservoir hosts of cowpox virus in British wildlife. Epidemiol Infect (1995) 1.65
Autosomal dominant sacral agenesis: Currarino syndrome. J Med Genet (2000) 1.64
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun (2006) 1.64
A female infant with features of Mohr and Majewski syndromes: variable expression, a genetic compound, or a distinct entity? J Med Genet (1983) 1.63
Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics (1994) 1.63
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet (2000) 1.62
A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol (1993) 1.61
Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study. Nephron (1998) 1.60
Granulocytic Ehrlichia infection in ixodid ticks and mammals in woodlands and uplands of the U.K. Med Vet Entomol (1998) 1.59
Health policy, student selection and curriculum reform. Health Policy Educ (1982) 1.59
Evidence of Bartonella henselae infection in cats and dogs in the United Kingdom. Vet Rec (2000) 1.59
Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res (1995) 1.57
The metaphase arrest technique. A critical review. Cell Tissue Kinet (1980) 1.57
Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat (2003) 1.57
A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br J Cancer (2001) 1.56
Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med (1987) 1.56
Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol (1983) 1.56
Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenat Diagn (1999) 1.55